UPB (Upstream Pharma) Kapitalisasi pasar

Upstream Bio Inc (UPB) is developing targeted therapy for severe asthma, supported by substantial capital that shields the business from market volatility. The development of unique antibodies could grant the company pricing power upon successful trial results. This daily price chart reflects a value of 0.15. Cost efficiency is achieved by outsourcing clinical trials to a network of external contractors, eliminating dependence on individual laboratories.

UPB upstreambio.com: Biji pasar ing interval 12.10.2024 - 22.10.2026

Rincian metrik lan analitis perusahaan Upstream Pharma (UPB)

Upstream Bio Inc (UPB): dhaptar indikator lan metrik:

Bagan rega Upstream Bio|UPB - Bagan tingkat prakiraan|Kapitalisasi pasar Upstream Pharma

Ringkesan analisis perusahaan:UPB (Upstream Bio)

Sampel barang Upstream Bio Inc

Market capitalization reflects the aggregate value of all the issuer's shares, serving as a tool for the continuous discounting of future cash flows by investors. Analyzing the market's aggregate valuation of Upstream Bio Inc (UPB) allows for tracking the impact of binary risks, where the metric's volatility correlates directly with the development success of the sole key antibody amid a high concentration of the product portfolio.

Pesaing Upstream Bio Inc (UPB)

Nilai pasar argenx ARGX|BNTX (BioNTech Inc.) - Biji pasar|Abivax S.A. - Kapitalisasi pasar|ADMA: Nilai pasar|Protagonist Therapeutics (PTGX) - Nilai pasar|Biji pasar IMVT (immunovant.com)|KNSA (Kiniksa) - Kapitalisasi pasar|GRFS: Nilai pasar|Kapitalisasi pasar ADPT|Kapitalisasi pasar Celldex Corp (CLDX)|Nilai pasar Aurinia Pharmaceuticals AUPH|Nilai pasar BCRX|VERA - Nilai pasar|Dianthus Therapeutics Inc (DNTH) - Biji pasar|PHVS: Kapitalisasi pasar|AbCellera Biologics Inc. (ABCL) - Kapitalisasi pasar|Biji pasar TRML|PGEN: Nilai pasar|Kapitalisasi pasar PHAR|Kapitalisasi pasar Nektar Therapeutics Inc|Nilai pasar Zenas Biopharma, Inc. ZBIO|IMNM - Biji pasar|GOSS - Nilai pasar|kalvista.com (KALV) - Biji pasar|SEPN (Septerna) - Biji pasar|Pieris Pharma (PVLA) - Kapitalisasi pasar|Nilai pasar Savara Corp|Kapitalisasi pasar RIGL (Rigel Corp)|Kapitalisasi pasar ANAB|ATXS - Nilai pasar|enGene - Biji pasar|Kapitalisasi pasar rapt.com RAPT|JBIO - Nilai pasar|Biji pasar ACRS|Kyverna Therapeutics (KYTX) - Nilai pasar|TLSA - Kapitalisasi pasar|Biji pasar CABA|VTYX (Ventyx Biosciences Inc.) - Nilai pasar|Nilai pasar Theratechnologies Inc (THTX)|AVTX (Avalo Therapeutics Inc) - Nilai pasar|Kapitalisasi pasar ELDN (Eledon Pharmaceuticals)|agenusbio.com (AGEN) - Nilai pasar|Climb Bio - Kapitalisasi pasar|ZURA - Kapitalisasi pasar|aTyr (ATYR) - Nilai pasar|Biji pasar Adagene Inc.|Biji pasar IMA|STTK: Nilai pasar|Kapitalisasi pasar EQ|Nilai pasar CNTB (connectbiopharm.com)|Kapitalisasi pasar IMUX (Immunic)|Kapitalisasi pasar Atara Biotherapeutics, Inc. (ATRA)|IFRX - Nilai pasar|Nilai pasar x4pharma.com|ACET (adicetbio.com) - Biji pasar|Celularity - Nilai pasar|INMB (INmune Bio Corp) - Kapitalisasi pasar|Barinthus Biotherapeutics Corp (BRNS) - Kapitalisasi pasar|Nilai pasar Kezar Life Sciences (KZR)|sabbiotherapeutics.com - Kapitalisasi pasar|Kapitalisasi pasar AKTX (Akari Therapeutics Plc)|ENLV - Biji pasar|QTTB: Biji pasar|GOVX - Kapitalisasi pasar|Edesa Biotech, Inc. (EDSA) - Nilai pasar|Biji pasar IBIO (ibioinc.com)|CARM (Carisma Therapeutics Inc) - Kapitalisasi pasar|Nilai pasar XTLB|Nilai pasar Bolt Biotherapeutics (BOLT)|HCWB: Biji pasar|Kapitalisasi pasar APVO (Aptevo Therapeutics Inc.)|Nilai pasar AIM|Aditxt Corp - Kapitalisasi pasar|GRI - Kapitalisasi pasar|XORTX (XRTX) - Nilai pasar|Vyome Therapeutics - Nilai pasar|Nilai pasar Revelation Biosciences|Biji pasar indaptusrx.com (INDP)|Kapitalisasi pasar SCNI|Kapitalisasi pasar calcimedica.com (CALI)|Affimed N.V. - Biji pasar|Nilai pasar ALLK|HOOKIPA - Kapitalisasi pasar|Kapitalisasi pasar IGM Biosciences, Inc. IGMS|iTeos Therapeutics, Inc. (ITOS) - Nilai pasar|Biji pasar Ocean Biomedical Inc|Nilai pasar TC BioPharm (Holdings) PLC|Biji pasar Third Harmonic Bio Inc (THRD)